AVACTA THERAPEUTICS - AVA6103 DEMONSTRATES CLEAN SAFETY PROFILE AT DOSE LEVEL 50% ABOVE MTD OF CONVENTIONAL EXATECAN

Reuters · 1d ago

Please log in to view news